QUERZOLI, Patrizia
 Distribuzione geografica
Continente #
NA - Nord America 330
EU - Europa 294
AS - Asia 59
AF - Africa 4
OC - Oceania 4
Totale 691
Nazione #
US - Stati Uniti d'America 329
SE - Svezia 106
FR - Francia 61
IT - Italia 59
CN - Cina 27
DE - Germania 25
NL - Olanda 10
GB - Regno Unito 6
HK - Hong Kong 6
BE - Belgio 5
VN - Vietnam 5
AU - Australia 4
ID - Indonesia 4
PL - Polonia 4
UA - Ucraina 4
AE - Emirati Arabi Uniti 3
FI - Finlandia 3
LB - Libano 3
HU - Ungheria 2
IN - India 2
KR - Corea 2
MA - Marocco 2
RO - Romania 2
RU - Federazione Russa 2
TW - Taiwan 2
CA - Canada 1
CH - Svizzera 1
CZ - Repubblica Ceca 1
EG - Egitto 1
HR - Croazia 1
IE - Irlanda 1
IL - Israele 1
IR - Iran 1
JP - Giappone 1
MY - Malesia 1
PK - Pakistan 1
PT - Portogallo 1
ZA - Sudafrica 1
Totale 691
Città #
Stockholm 106
Ashburn 44
Santa Cruz 34
Ferrara 18
Chicago 16
Fairfield 15
Los Angeles 9
Boardman 8
Bremen 8
Des Moines 7
Houston 7
San Diego 7
Woodbridge 7
Amsterdam 6
Brooklyn 6
Buffalo 6
Seattle 6
Dallas 5
Dong Ket 5
New York 5
Paris 5
San Jose 5
Cedar Knolls 4
Central 4
Fleming Island 4
Heilbronn 4
Padova 4
Warsaw 4
Wilmington 4
Agna 3
Bassano Del Grappa 3
Bologna 3
Frankfurt am Main 3
Frisco 3
Grenoble 3
Hangzhou 3
Helsinki 3
Liedekerke 3
Milan 3
Shanghai 3
Ancona 2
Beijing 2
Calvanico 2
Cambridge 2
Columbus 2
Crugers 2
Dulles 2
Hanover 2
Henderson 2
Hong Kong 2
Jakarta 2
Las Vegas 2
Livonia 2
London 2
Midlothian 2
Milpitas 2
Nice 2
Pistoia 2
Sunnyvale 2
Sydney 2
Taipei 2
Acerra 1
Adelaide 1
Ahmedabad 1
Anchorage 1
Ascoli Piceno 1
Aveiro 1
Baltimore 1
Beirut 1
Bellevue 1
Budapest 1
Cairo 1
Casoria 1
Castro Valley 1
Catania 1
Ceyrat 1
Chesterfield 1
Council Bluffs 1
Dublin 1
Duncan 1
Easley 1
Ferrara di Monte Baldo 1
Florence 1
Hebei 1
Herndon 1
Jersey City 1
Johannesburg 1
Kidlington 1
Kuala Lumpur 1
Lahore 1
Lake Forest 1
Leeds 1
Leuven 1
Lincoln 1
Lombard 1
Madison 1
Menlo Park 1
Molenbeek-Saint-Jean 1
Nazareth 1
New Orleans 1
Totale 477
Nome #
High-sensitivity assay for monitoring ESR1 mutations in circulating cell-free DNA of breast cancer patients receiving endocrine therapy, file e309ade2-acd1-3969-e053-3a05fe0a2c94 130
HER2-Positive Lobular Versus Ductal Carcinoma of the Breast: Pattern of First Recurrence and Molecular Insights, file e309ade2-a27d-3969-e053-3a05fe0a2c94 89
Phospholipase C-beta2 promotes mitosis and migration of human breast cancer-derived cells, file e309ade0-2199-3969-e053-3a05fe0a2c94 69
MicroRNA profiling for the identification of cancers with unknown primary tissue-of-origin, file e309ade2-baa8-3969-e053-3a05fe0a2c94 59
Axyllary lymph node nanometastases are prognostic factors for disease-free survival and metastatic relapse in breast cancer patiensts, file e309ade0-2272-3969-e053-3a05fe0a2c94 51
Diagnostic and prognostic microRNAs in the serum of breast cancer patients measured by droplet digital PCR, file e309ade0-c0d6-3969-e053-3a05fe0a2c94 35
Serologic investigation on undifferentiated nasopharyngeal carcinoma and Simian Virus 40 infection, file e309ade0-212d-3969-e053-3a05fe0a2c94 23
p53 status identifies two subgroups of triple-negative breast cancers with distinct biological features, file 729a3f2f-d261-4111-b2ba-b8a823b1d5b7 22
miR-125b targets erythropoietin and its receptor and their expression correlates with metastatic potential and ERBB2/HER2 expression, file e309ade0-8f1e-3969-e053-3a05fe0a2c94 16
Solid papillary breast carcinomas resembling the tall cell variant of papillary thyroid neoplasms (solid papillary carcinomas with reverse polarity) harbour recurrent mutations affecting IDH2 and PIK3CA: a validation cohort, file e309ade5-2d4a-3969-e053-3a05fe0a2c94 16
Positive predictive value for malignancy on surgical excision of breast lesions of uncertain malignant potential (B3) diagnosed by stereotactic vacuum-assisted needle core biopsy (VANCB): a large multi-insitutional study in Italy, file 75793d5c-8628-4e81-8174-2b5b170b8588 15
Estrogen receptor mutation: a new strategy to overcome endocrine resistance, file 8f1c9a9a-391d-441b-b9b3-8c9803bb2d76 15
Axillary lymph node nanometastases are prognostic factors for metastatic relapse, file ae8640c6-76b6-474d-9f25-75da45594f19 15
Il protocollo Diagnostico-Terapeutico e Assistenziale per il carcinoma mammario della Regione Emilia-Romagna. I edizione, file e309ade1-fbc8-3969-e053-3a05fe0a2c94 13
PLC-β2 is highly expressed in breast cancer and is associated with a poor outcome: A study on tissue microarrays, file e309ade0-2b22-3969-e053-3a05fe0a2c94 12
Prognostic and predictive factors related to metastatic breast cancer clinical history: an outcome study [Fattori prognostici e predittivi nella storia clinica del carcinoma metastatico della mammella: Uno studio di esito], file 5cfaaf2e-deff-47be-a405-a0b03fe30949 11
Tumor infiltrating lymphocytes in triple negative breast cancer and correlations with prognosis, file 9c6d6fff-3161-4ec0-97c9-89c42ffa924a 11
Biology, prognosis and response to therapy of breast carcinomas according to HER2 score, file e7f3ee43-f787-462f-a7ac-ae31804c7e38 11
Tumour infiltrating lymphocytes and tumour associated macrophages in chronic obstructive pulmonary disease (COPD) patients with non-small cell lung cancer (NSCLC) and in patients with NSCLC, file f2237081-f043-46e1-9077-c258f615ecc2 11
Differential expression of heme oxygenase (HO)-1 in macrophages of lung tumour and tumour-free lung tissues, file 2d111f52-a17d-4a88-8f31-c0b4d89c20fa 9
Increased overall survival independent of RECIST response in metastatic breast cancer patients continuing trastuzumab treatment: Evidence from a retrospective study, file b36c2b63-ef3c-4480-a949-14d32151c6d5 9
Diagnostic and prognostic microRNAs in the serum of breast cancer patients measured by droplet digital PCR, file e309ade0-c80f-3969-e053-3a05fe0a2c94 9
Cytoplasmic Trop-1/Ep-CAM Overexpression is Associated with a Favorable Outcome in Node-positive Breast Cancer, file e4303740-29b5-4d56-bd03-0306717d5cd9 8
MicroRNA profiling for the identification of cancers with unknown primary tissue-of-origin, file e309ade0-3089-3969-e053-3a05fe0a2c94 6
CD8+ T cells expressing IL-10 are associated with a favourable prognosis in lung cancer, file e309ade0-3268-3969-e053-3a05fe0a2c94 6
Sex Hormone receptor levels in laryngeal carcinoma: a comparison between protein and RNA evaluations, file e309ade0-e826-3969-e053-3a05fe0a2c94 6
Modulation of biomarkers in minimal breast carcinoma, file e309ade5-2bca-3969-e053-3a05fe0a2c94 6
Significant correlation between interleukin-10 expression and progression of non-small cell lung cancer through heme oxygenase, file f2549483-ebcd-415e-b109-8a56fb31b290 6
Treatment of a relapsing facial pyoderma gangrenosum (malignant pyoderma), file e309ade0-4855-3969-e053-3a05fe0a2c94 5
Lymph node micrometastases do influence breast cancer outcome, file e309ade1-394f-3969-e053-3a05fe0a2c94 4
Decreased heme-oxygenase (HO)-1 in the macrophages of non-small cell lung cancer, file e309ade0-2242-3969-e053-3a05fe0a2c94 3
High expression of 90K (Mac-2 BP) is associated with poor survival in node-negative breast cancer patients not receiving adjuvant systemic therapies, file e309ade0-2932-3969-e053-3a05fe0a2c94 1
null, file e309ade0-30df-3969-e053-3a05fe0a2c94 1
Breast Cancer and Simian Virus 40 Infection, file e309ade0-3fa5-3969-e053-3a05fe0a2c94 1
null, file e309ade0-a87b-3969-e053-3a05fe0a2c94 1
An international study comparing conventional versus mRNA level testing (TargetPrint) for ER, PR, and HER2 status of breast cancer, file e309ade1-33b7-3969-e053-3a05fe0a2c94 1
null, file e309ade2-17f5-3969-e053-3a05fe0a2c94 1
HER2-Positive Lobular Versus Ductal Carcinoma of the Breast: Pattern of First Recurrence and Molecular Insights, file e309ade2-1b02-3969-e053-3a05fe0a2c94 1
Totale 708
Categoria #
all - tutte 3.719
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.719


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202010 3 1 0 0 0 1 0 0 0 0 1 4
2020/202152 2 3 4 8 4 3 6 0 2 4 8 8
2021/2022126 13 2 8 2 9 1 9 9 14 7 32 20
2022/2023322 11 15 32 20 32 21 24 61 54 18 25 9
2023/2024190 15 29 7 5 37 30 11 29 27 0 0 0
Totale 708